Global Market Access Solutions is able to add value to your product portfolio with the following capabilities:

• Market access and pricing strategy development for pharmaceutical, biopharmaceutical and medical device products
• Pricing and reimbursement evaluation of early and late stage products to inform go/no-go opportunities as well as investment and divestment opportunities
• Health investment modeling to estimate the value of investing in medical technologies (see special section on health investment modeling)
• Pharmaceutical policy evaluation using large prescribing and prescription datasets
• ‘Value-based pricing’ evaluations using cost-effectiveness analysis, cost-utility analysis, and budget impact analysis
• Health economic, burden of illness, and quality of life key message development
• Patient survey and compliance studies  
• Strategic input to clinical development programs to capture product value
• Global product value dossiers and reimbursement applications to support local pricing and reimbursement negotiations
• Media-friendly value messaging and medical writing capability including medical manuscripts, press materials, and sales aids.

To discuss your specific needs please contact Mark Connolly: mark@gmasoln.com.